Structures by: Smith A. J.
Total: 25
C15H10O7,C6H6N2O
C15H10O7,C6H6N2O
Molecular pharmaceutics (2011) 8, 5 1867-1876
a=4.9780(10)Å b=12.636(3)Å c=15.571(3)Å
α=110.53(3)° β=97.63(3)° γ=99.39(3)°
C15H10O7,C8H10N4O2,CH4O
C15H10O7,C8H10N4O2,CH4O
Molecular pharmaceutics (2011) 8, 5 1867-1876
a=10.3089(3)Å b=14.8531(4)Å c=15.1994(5)Å
α=90.00° β=100.612(2)° γ=90.00°
Pa Br4
Br4Pa
Journal of the Chemical Society A: Inorganic, Physical, Theoretical (1966-1971) (1971) 1971, 908-910
a=8.824Å b=8.824Å c=7.957Å
α=90° β=90° γ=90°
K2 (Pa F7)
F7K2Pa
Journal of the Chemical Society A: Inorganic, Physical, Theoretical (1966-1971) (1967) 1967, 1429-1434
a=13.76Å b=6.742Å c=8.145Å
α=90° β=125.17° γ=90°
C24H31HfN3
C24H31HfN3
Dalton transactions (Cambridge, England : 2003) (2013) 42, 45 16056-16065
a=10.5097(2)Å b=12.3812(2)Å c=33.8422(5)Å
α=90.00° β=90.00° γ=90.00°
C24H31HfN3
C24H31HfN3
Dalton transactions (Cambridge, England : 2003) (2014) 43, 11 4593-4602
a=10.5097(2)Å b=12.3812(2)Å c=33.8422(5)Å
α=90.00° β=90.00° γ=90.00°
Tetraglycine
C8H14N4O5
CrystEngComm (2014) 16, 31 7196
a=4.8042(2)Å b=14.8701(5)Å c=15.6243(5)Å
α=67.284(3)° β=85.298(3)° γ=88.190(3)°
Pentaglycine
C10H17N5O6
CrystEngComm (2014) 16, 31 7196
a=4.7995(3)Å b=14.9108(15)Å c=17.6905(19)Å
α=90.203(8)° β=94.866(7)° γ=91.976(7)°
Tetraglycine
C8H14N4O5
CrystEngComm (2014) 16, 31 7196
a=4.8042(2)Å b=14.8701(5)Å c=15.6243(5)Å
α=67.284(3)° β=85.298(3)° γ=88.190(3)°
Pentaglycine
C10H17N5O6
CrystEngComm (2014) 16, 31 7196
a=4.7995(3)Å b=14.9108(15)Å c=17.6905(19)Å
α=90.203(8)° β=94.866(7)° γ=91.976(7)°
K4 Th (C2 O4)4 (H2 O)4
C8H8K4O20Th
Acta Crystallographica B (24,1968-38,1982) (1975) 31, 1361-1366
a=9.562Å b=13.087Å c=10.387Å
α=115.75° β=80.9° γ=112.66°
Pa O Br3
Br3OPa
Acta Crystallographica B (24,1968-38,1982) (1975) 31, 1382-1385
a=16.911Å b=3.871Å c=9.334Å
α=90° β=113.67° γ=90°
(La Ta3 O9)0.6667
La0.667O4.25Ta2
Acta Crystallographica (1,1948-23,1967) (1967) 23, 740-746
a=3.918Å b=3.918Å c=7.913Å
α=90° β=90° γ=90°
(La Nb3 O9)0.6667
La0.6667Nb2.0001O6.0003
Acta Crystallographica (1,1948-23,1967) (1967) 23, 740-746
a=3.911Å b=3.911Å c=7.908Å
α=90° β=90° γ=90°
C4H18N8O13S2Th1,2(H2O1)
C4H18N8O13S2Th1,2(H2O1)
Acta Crystallographica Section C (1991) 47, 8 1595-1597
a=16.170(10)Å b=8.150(10)Å c=32.010(10)Å
α=90° β=93.52(4)° γ=90°
C36H72Br3Li3O36
C36H72Br3Li3O36
Crystal Growth & Design (2014) 14, 11 6135
a=16.2665(2)Å b=16.2665(2)Å c=17.0945(5)Å
α=90.00° β=90.00° γ=120.00°
C19H17FN2O5
C19H17FN2O5
ACS combinatorial science (2012) 14, 3 218-223
a=8.3881(16)Å b=11.532(2)Å c=18.652(3)Å
α=90.00° β=97.9160(10)° γ=90.00°
C28H25ClN4O9,0.67(CHCl3),0.33(CH2Cl2)
C28H25ClN4O9,0.67(CHCl3),0.33(CH2Cl2)
ACS combinatorial science (2012) 14, 3 218-223
a=7.7789(8)Å b=13.1511(13)Å c=16.1282(16)Å
α=76.6690(10)° β=84.6000(10)° γ=77.9440(10)°
C22H24FN3O4,H2O
C22H24FN3O4,H2O
ACS combinatorial science (2012) 14, 3 218-223
a=13.4864(13)Å b=20.1959(19)Å c=16.1652(15)Å
α=90.00° β=90.179(2)° γ=90.00°
L2Zn3
CH2Cl2,C42H44N6O2Zn3
Organometallics (2016) 35, 15 2429
a=11.4222(17)Å b=13.761(2)Å c=26.609(4)Å
α=90.00° β=100.522(2)° γ=90.00°
NiZnCl2TolylPyBipy
C33H31N5O3NiZnCl2,C7H8,C4H8O
Organometallics (2016) 35, 15 2429
a=9.3954(11)Å b=13.4704(16)Å c=19.244(2)Å
α=86.949(2)° β=84.767(2)° γ=80.539(2)°
NiTolylPy
C5H5N,C43H32N4NiO
Organometallics (2016) 35, 15 2429
a=11.9581(13)Å b=12.6258(14)Å c=14.9802(17)Å
α=66.383(2)° β=67.701(2)° γ=73.736(2)°
GaLiS2
GaLiS2
Acta Crystallographica, Section C (1990) 46, 2017-2019
a=6.519Å b=7.872Å c=6.238Å
α=90° β=90° γ=90°
Cl3O6Y
Cl3O6Y
Acta Crystallographica, Section C (1990) 46, 960-962
a=7.8346Å b=6.4729Å c=9.5817Å
α=90° β=93.768° γ=90°
Na2O18S3Th
Na2O18S3Th
Acta Crystallographica, Section C (1990) 46, 957-960
a=5.567Å b=16.81Å c=15.76Å
α=90° β=91.925° γ=90°